These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 38073096)

  • 1. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms.
    Liu S; He Y; Zhang Y; Zhang Z; Huang K; Deng L; Liao B; Zhong Y; Feng J
    Gut Microbes; 2023 Dec; 15(2):2290331. PubMed ID: 38073096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on gut microbiota in cardiovascular diseases.
    Qian B; Zhang K; Li Y; Sun K
    Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
    Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
    Cardiovasc Hematol Agents Med Chem; 2024; 22(3):375-389. PubMed ID: 38275032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
    Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
    Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
    Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
    Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
    Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota derived metabolites in cardiovascular health and disease.
    Wang Z; Zhao Y
    Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
    Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
    J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of Gut Microbiota in Cardiovascular Diseases.
    Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
    Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
    Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
    Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota is a potential goalkeeper of dyslipidemia.
    Lei L; Zhao N; Zhang L; Chen J; Liu X; Piao S
    Front Endocrinol (Lausanne); 2022; 13():950826. PubMed ID: 36176475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
    Nogal A; Valdes AM; Menni C
    Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.
    Yntema T; Koonen DPY; Kuipers F
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
    Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
    BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease.
    Cuervo L; McAlpine PL; Olano C; Fernández J; Lombó F
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.